// App-Quantinova.ai

2889 : A novel serum biomarker identifying Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Researchers

Presenter

  • D. Chatterjee

Principal Investigators

  • M. Fatah

  • D. Adkis

  • D A. Spears

  • T. Koopmann

  • K. Mittal

  • C. Brunckhorst

  • F. Duri

  • A. Saguner

  • R M. Hamilton

Medical Centers

  • University of Toronto, Pediatrics (Cardiology), Toronto, Canada

  • University Hospital Zurich, Zurich ARVC Program, Zurich, Switzerland

  • University Health Network, Medicine, Toronto, Canada

  • Leiden University Medical Centre, Leiden, Netherlands

Locations

  • Canada

  • Switzerland

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved